Synthesis of 1,10‐phenanthroline‐2,9‐bistriazoles: Evaluation as G‐quadruplex binders and anti‐tumor activity

Joana Figueiredo,Israel Carreira-Barral,Pedro Lourenço,André Miranda,Jéssica Lopes Nunes,Roberto Quesada,Mafalda Laranjo,Jean-Louis Mergny,Carla Cruz
DOI: https://doi.org/10.1002/cmdc.202400591
IF: 3.54
2024-11-04
ChemMedChem
Abstract:Novel 1,10‐phenanthroline‐2,9‐bistriazoles derivatives have been synthesized by copper‐catalyzed azide/alkyne cycloaddition reactions and assessed for their ability to bind and stabilize G‐quadruplex (G4) structures. Ten novel compounds were evaluated using Förster resonance energy transfer (FRET) melting, circular dichroism (CD), and fluorescence spectroscopy on several G4 sequences. Biophysical characterization led to the identification of compounds 4a, 4b, and 5b as good G4 ligands of KRAS G4 sequences. The cell viability of all derivatives was also assessed, revealing weak effects. However, compound 2a exhibited cytotoxicity activity on A549 and H1299 cancer cells and low cytotoxicity towards non‐malignant cells MRC‐5 not connected with its G4‐binding ability. Flow cytometry showed that 2a induced a cell viability decrease in S and G2/M phases for A549 and H1299; thus, more studies should be performed to explore the proteins involved in cell cycle regulation.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?